NYU Langone Health announced that, for the third time, a genetically modified pig kidney had been transplanted into a living ...

Xenotransplantation—using pig or other non-human cells, tissues, and organs to address human medical conditions—holds potential to address the urgent shortage of transplantable organs. Every ...

The integration of artificial intelligence (AI) in the biotech industry seems boundless. Its combination with CRISPR could be the one area where AI has the most potential. Nobel prize winner and ...

Xenotransplantation—using pig or other non-human cells, tissues, and organs to address human medical conditions—holds potential to address the urgent shortage of transplantable organs. Every day, an ...

A n Alabama woman who had been on the waiting list for a kidney transplant since 2017 just became the third-ever recipient of ...

Patients battling the physical and emotional toll of kidney disease are urging action to advance clinical trials in xenotransplantation, according to the NKF report. Xenotransplantation?

Revivicor, the biotech company Ayares leads, is at the forefront of xenotransplantation research — the implantation of animal organs into humans — which aims to solve a chronic organ shortage that has ...

The Food and Drug Administration (FDA) approved CRISPR Therapeutics' (NASDAQ: CRSP) first treatment last December, and its successful launch could push the stock much higher. Investment bank ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...